Meningococcal Group B Vaccine Market
1 Study Coverage
1.1 Meningococcal Group B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Market by Application
1.3.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Meningococcal Group B Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Meningococcal Group B Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Meningococcal Group B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Meningococcal Group B Vaccine Sales by Region
2.4.1 Global Meningococcal Group B Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Meningococcal Group B Vaccine by Region (2023-2028)
2.5 Global Meningococcal Group B Vaccine Revenue by Region
2.5.1 Global Meningococcal Group B Vaccine Revenue by Region (2017-2022)
2.5.2 Global Meningococcal Group B Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Meningococcal Group B Vaccine Sales by Manufacturers
3.1.1 Global Top Meningococcal Group B Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Group B Vaccine in 2021
3.2 Global Meningococcal Group B Vaccine Revenue by Manufacturers
3.2.1 Global Meningococcal Group B Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Group B Vaccine Revenue in 2021
3.3 Global Meningococcal Group B Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Meningococcal Group B Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Meningococcal Group B Vaccine Sales by Type
4.1.1 Global Meningococcal Group B Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Meningococcal Group B Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Meningococcal Group B Vaccine Revenue by Type
4.2.1 Global Meningococcal Group B Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Meningococcal Group B Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Meningococcal Group B Vaccine Price by Type
4.3.1 Global Meningococcal Group B Vaccine Price by Type (2017-2022)
4.3.2 Global Meningococcal Group B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Meningococcal Group B Vaccine Sales by Application
5.1.1 Global Meningococcal Group B Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Meningococcal Group B Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Meningococcal Group B Vaccine Revenue by Application
5.2.1 Global Meningococcal Group B Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Meningococcal Group B Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Meningococcal Group B Vaccine Price by Application
5.3.1 Global Meningococcal Group B Vaccine Price by Application (2017-2022)
5.3.2 Global Meningococcal Group B Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Meningococcal Group B Vaccine Market Size by Type
6.1.1 North America Meningococcal Group B Vaccine Sales by Type (2017-2028)
6.1.2 North America Meningococcal Group B Vaccine Revenue by Type (2017-2028)
6.2 North America Meningococcal Group B Vaccine Market Size by Application
6.2.1 North America Meningococcal Group B Vaccine Sales by Application (2017-2028)
6.2.2 North America Meningococcal Group B Vaccine Revenue by Application (2017-2028)
6.3 North America Meningococcal Group B Vaccine Market Size by Country
6.3.1 North America Meningococcal Group B Vaccine Sales by Country (2017-2028)
6.3.2 North America Meningococcal Group B Vaccine Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Meningococcal Group B Vaccine Market Size by Type
7.1.1 Europe Meningococcal Group B Vaccine Sales by Type (2017-2028)
7.1.2 Europe Meningococcal Group B Vaccine Revenue by Type (2017-2028)
7.2 Europe Meningococcal Group B Vaccine Market Size by Application
7.2.1 Europe Meningococcal Group B Vaccine Sales by Application (2017-2028)
7.2.2 Europe Meningococcal Group B Vaccine Revenue by Application (2017-2028)
7.3 Europe Meningococcal Group B Vaccine Market Size by Country
7.3.1 Europe Meningococcal Group B Vaccine Sales by Country (2017-2028)
7.3.2 Europe Meningococcal Group B Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Meningococcal Group B Vaccine Market Size by Type
8.1.1 Asia Pacific Meningococcal Group B Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Meningococcal Group B Vaccine Market Size by Application
8.2.1 Asia Pacific Meningococcal Group B Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Meningococcal Group B Vaccine Market Size by Region
8.3.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Meningococcal Group B Vaccine Market Size by Type
9.1.1 Latin America Meningococcal Group B Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Meningococcal Group B Vaccine Revenue by Type (2017-2028)
9.2 Latin America Meningococcal Group B Vaccine Market Size by Application
9.2.1 Latin America Meningococcal Group B Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Meningococcal Group B Vaccine Revenue by Application (2017-2028)
9.3 Latin America Meningococcal Group B Vaccine Market Size by Country
9.3.1 Latin America Meningococcal Group B Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Meningococcal Group B Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Group B Vaccine Market Size by Type
10.1.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Meningococcal Group B Vaccine Market Size by Application
10.2.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Meningococcal Group B Vaccine Market Size by Country
10.3.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Meningococcal Group B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Meningococcal Group B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Meningococcal Group B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Meningococcal Group B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Meningococcal Group B Vaccine Industry Chain Analysis
12.2 Meningococcal Group B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Meningococcal Group B Vaccine Production Mode & Process
12.4 Meningococcal Group B Vaccine Sales and Marketing
12.4.1 Meningococcal Group B Vaccine Sales Channels
12.4.2 Meningococcal Group B Vaccine Distributors
12.5 Meningococcal Group B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Meningococcal Group B Vaccine Industry Trends
13.2 Meningococcal Group B Vaccine Market Drivers
13.3 Meningococcal Group B Vaccine Market Challenges
13.4 Meningococcal Group B Vaccine Market Restraints
14 Key Findings in The Global Meningococcal Group B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Group B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Bexsero
Table 3. Major Manufacturers of Trumenba
Table 4. Major Manufacturers of Other
Table 5. Global Meningococcal Group B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Meningococcal Group B Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Meningococcal Group B Vaccine Sales by Region (2017-2022) & (K Units)
Table 8. Global Meningococcal Group B Vaccine Sales Market Share by Region (2017-2022)
Table 9. Global Meningococcal Group B Vaccine Sales by Region (2023-2028) & (K Units)
Table 10. Global Meningococcal Group B Vaccine Sales Market Share by Region (2023-2028)
Table 11. Global Meningococcal Group B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2017-2022)
Table 13. Global Meningococcal Group B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2023-2028)
Table 15. Global Meningococcal Group B Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Meningococcal Group B Vaccine Sales Share by Manufacturers (2017-2022)
Table 17. Global Meningococcal Group B Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 19. Meningococcal Group B Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2021)
Table 22. Meningococcal Group B Vaccine Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Meningococcal Group B Vaccine Product Offered
Table 24. Date of Manufacturers Enter into Meningococcal Group B Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 27. Global Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 28. Global Meningococcal Group B Vaccine Sales Share by Type (2017-2022)
Table 29. Global Meningococcal Group B Vaccine Sales Share by Type (2023-2028)
Table 30. Global Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Meningococcal Group B Vaccine Revenue Share by Type (2017-2022)
Table 33. Global Meningococcal Group B Vaccine Revenue Share by Type (2023-2028)
Table 34. Meningococcal Group B Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Meningococcal Group B Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 37. Global Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 38. Global Meningococcal Group B Vaccine Sales Share by Application (2017-2022)
Table 39. Global Meningococcal Group B Vaccine Sales Share by Application (2023-2028)
Table 40. Global Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Meningococcal Group B Vaccine Revenue Share by Application (2017-2022)
Table 43. Global Meningococcal Group B Vaccine Revenue Share by Application (2023-2028)
Table 44. Meningococcal Group B Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Meningococcal Group B Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. North America Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. North America Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 51. North America Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 52. North America Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. North America Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. North America Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. Europe Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. Europe Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 63. Europe Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 64. Europe Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Meningococcal Group B Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Meningococcal Group B Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Meningococcal Group B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Meningococcal Group B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Meningococcal Group B Vaccine Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Meningococcal Group B Vaccine Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Meningococcal Group B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Meningococcal Group B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 106. GSK Corporation Information
Table 107. GSK Description and Major Businesses
Table 108. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. GSK Meningococcal Group B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. GSK Recent Developments
Table 111. Pfizer Corporation Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Pfizer Meningococcal Group B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Meningococcal Group B Vaccine Distributors List
Table 119. Meningococcal Group B Vaccine Customers List
Table 120. Meningococcal Group B Vaccine Market Trends
Table 121. Meningococcal Group B Vaccine Market Drivers
Table 122. Meningococcal Group B Vaccine Market Challenges
Table 123. Meningococcal Group B Vaccine Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Group B Vaccine Product Picture
Figure 3. Global Meningococcal Group B Vaccine Market Share by Type in 2021 & 2028
Figure 3. Bexsero Product Picture
Figure 4. Trumenba Product Picture
Figure 5. Other Product Picture
Figure 6. Global Meningococcal Group B Vaccine Market Share by Application in 2021 & 2028
Figure 7. Public
Figure 8. Private
Figure 9. Meningococcal Group B Vaccine Report Years Considered
Figure 10. Global Meningococcal Group B Vaccine Sales 2017-2028 (K Units)
Figure 11. Global Meningococcal Group B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Meningococcal Group B Vaccine Revenue 2017-2028 (US$ Million)
Figure 13. Global Meningococcal Group B Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Meningococcal Group B Vaccine Sales Market Share by Region (2017-2022)
Figure 15. Global Meningococcal Group B Vaccine Sales Market Share by Region (2023-2028)
Figure 16. North America Meningococcal Group B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 17. North America Meningococcal Group B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Meningococcal Group B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Meningococcal Group B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Meningococcal Group B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Meningococcal Group B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Meningococcal Group B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Meningococcal Group B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Meningococcal Group B Vaccine Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Meningococcal Group B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Meningococcal Group B Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Meningococcal Group B Vaccine in the World: Market Share by Meningococcal Group B Vaccine Revenue in 2021
Figure 28. Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 32. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 33. North America Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 34. North America Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. North America Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 36. North America Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America Meningococcal Group B Vaccine Sales Share by Country (2017-2028)
Figure 38. North America Meningococcal Group B Vaccine Revenue Share by Country (2017-2028)
Figure 39. the United States Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 42. Europe Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Meningococcal Group B Vaccine Sales Share by Country (2017-2028)
Figure 46. Europe Meningococcal Group B Vaccine Revenue Share by Country (2017-2028)
Figure 47. Germany Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. France Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. UK Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Meningococcal Group B Vaccine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Meningococcal Group B Vaccine Revenue Share by Region (2017-2028)
Figure 58. China Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. India Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Latin America Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Latin America Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Meningococcal Group B Vaccine Sales Share by Country (2017-2028)
Figure 72. Latin America Meningococcal Group B Vaccine Revenue Share by Country (2017-2028)
Figure 73. Mexico Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Meningococcal Group B Vaccine Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Meningococcal Group B Vaccine Revenue Share by Country (2017-2028)
Figure 82. Turkey Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Meningococcal Group B Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Meningococcal Group B Vaccine Value Chain
Figure 86. Meningococcal Group B Vaccine Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Industry Market Size
